Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan Universitygrid.428986.9, Haikou, China.
One Health Institute, Hainan Universitygrid.428986.9, Haikou, China.
Microbiol Spectr. 2022 Oct 26;10(5):e0182922. doi: 10.1128/spectrum.01829-22. Epub 2022 Aug 16.
Serratia marcescens (S. marcescens) is an environmental bacterium that causes infections with high morbidity and mortality. Notably, infections caused by multidrug-resistant S. marcescens have become a global public health issue. Therefore, the discovery of promising compounds to reduce the virulence of pathogens and restore antibiotic activity against multidrug-resistant bacteria is critical. Quorum sensing (QS) regulates virulence factors and biofilm formation of microorganisms to increase their pathogenicity and is, therefore, an important factor in the formation of multidrug resistance. In this study, we found that 3-phenylpropan-1-amine (3-PPA) inhibited S. marcescens NJ01 biofilm formation and virulence factors, including prodigiosin, protease, lipase, hemolysin, and swimming. The combination of 3-PPA (50.0 μg/mL) and ofloxacin (0.2 μg/mL) enhanced S. marcescens NJ01 sensitivity to ofloxacin. Based on crystalline violet staining, scanning electron microscopy (SEM), and confocal laser scanning microscopy (CLSM), 3-PPA (50.0 μg/mL) reduced S. marcescens NJ01 biofilm formation by 48%. Quantitative real-time PCR (qRT-PCR) showed that 3-PPA regulated the expression of virulence- and biofilm-related genes , , , , , , and . Liquid chromatography-tandem mass spectrometry (LC-MS/MS) indicated that 3-PPA affected intracellular metabolites of S. marcescens NJ01, leading to reduce metabolic activity. These results suggested that 3-PPA inhibits the pathogenicity of S. marcescens NJ01 by occluding QS. Thus, 3-PPA is feasible as an ofloxacin adjuvant to overcome multidrug-resistant S. marcescens and improve the treatment of intractable infections. Multidrug-resistant bacteria have become a major threat to global public health, leading to increased morbidity, mortality, and health care costs. Bacterial virulence factors and biofilms, which are regulated by quorum sensing (QS), are the primary causes of multidrug resistance. In this study, 3-PPA reduced virulence factors and eliminated biofilm formation by inhibiting QS in S. marcescens NJ01 bacteria, without affecting bacterial growth, thus restoring sensitivity to ofloxacin. Thus, the discovery of compounds that can restore antibiotic activity against bacteria is a promising strategy to mitigate multidrug resistance in pathogens.
粘质沙雷氏菌(Serratia marcescens)是一种环境细菌,可引起高发病率和死亡率的感染。值得注意的是,由多药耐药粘质沙雷氏菌引起的感染已成为全球公共卫生问题。因此,发现有前途的化合物来降低病原体的毒力并恢复对抗多药耐药菌的抗生素活性至关重要。群体感应(QS)调节微生物的毒力因子和生物膜形成,以增加其致病性,因此是多药耐药形成的重要因素。在这项研究中,我们发现 3-苯丙胺(3-PPA)抑制粘质沙雷氏菌 NJ01 生物膜形成和毒力因子,包括灵菌红素、蛋白酶、脂肪酶、溶血素和泳动。3-PPA(50.0μg/mL)和氧氟沙星(0.2μg/mL)的组合增强了粘质沙雷氏菌 NJ01 对氧氟沙星的敏感性。基于结晶紫染色、扫描电子显微镜(SEM)和共聚焦激光扫描显微镜(CLSM),3-PPA(50.0μg/mL)将粘质沙雷氏菌 NJ01 的生物膜形成减少了 48%。实时荧光定量 PCR(qRT-PCR)显示,3-PPA 调节了毒力和生物膜相关基因的表达, , , , , , 。液相色谱-串联质谱(LC-MS/MS)表明,3-PPA 影响了粘质沙雷氏菌 NJ01 的细胞内代谢物,导致代谢活性降低。这些结果表明,3-PPA 通过阻断 QS 抑制粘质沙雷氏菌 NJ01 的致病性。因此,3-PPA 可作为克服多药耐药粘质沙雷氏菌的氧氟沙星佐剂,改善难治性感染的治疗效果。 多药耐药菌已成为全球公共卫生的主要威胁,导致发病率、死亡率和医疗保健成本增加。细菌毒力因子和生物膜受群体感应(QS)调节,是多药耐药的主要原因。在这项研究中,3-PPA 通过抑制粘质沙雷氏菌 NJ01 细菌的 QS 减少了毒力因子并消除了生物膜形成,而不影响细菌生长,从而恢复了对氧氟沙星的敏感性。因此,发现可以恢复抗生素对细菌活性的化合物是减轻病原体多药耐药性的一种有前途的策略。